Literature DB >> 22053838

The prevalence and risk factors of ocular trauma: the Singapore Indian eye study.

Daniel Chua1, Wanling Wong, Ecosse L Lamoureux, Tin Aung, Seang-Mei Saw, Tien Y Wong.   

Abstract

PURPOSE: To describe the prevalence and risk factors of ocular trauma in an urban Southeast Asian population.
METHODS: A population-based survey of 3,400 (75.6% response rate) adults of Indian ethnicity aged 40-80 years residing in Singapore was conducted in 2007-2009. An age-stratified (10-year age group) random sampling procedure was performed to select participants. Ocular trauma was defined as any eye injury requiring medical attention and any history of ocular trauma was documented using a standardized and validated questionnaire comprising seven questions. Potential risk factors associated with ocular trauma included age, gender, socioeconomic status, occupation, housing type, alcohol consumption, smoking, diabetes mellitus, hypertension and history of falls.
RESULTS: Ocular trauma was reported in 5.1% (n = 162; 95% confidence interval [CI] 4.3-6.1%) of the study population, of whom 26.5% (n = 43) required hospitalization. A total of 42.0% (n = 68) of cases resulted from a blunt object, 36.4% (n = 59) from a sharp object, and 15.4% (n = 25) from chemical burns. After adjusting for age and sex, men had a higher prevalence of ocular trauma (7.1% vs. 3.0%, age-adjusted odds ratio [OR] 2.2, 95% CI 1.6-3.1). A history of cigarette smoking was associated with higher likelihood of ocular trauma (OR 1.6, 95% CI 1.1-2.4) but not consumption of alcohol (OR 1.0, 95% CI 0.6-1.6).
CONCLUSIONS: One in twenty Indian adults in this urban Southeast Asian population had a history of ocular trauma, similar to the prevalence reported in Malays living in Singapore. Men and cigarette smokers were more likely to have incurred ocular trauma.

Entities:  

Mesh:

Year:  2011        PMID: 22053838     DOI: 10.3109/09286586.2011.628775

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  7 in total

Review 1.  Causes, occupational risk and socio-economic determinants of eye injuries: a literature review.

Authors:  Elli DO Kyriakaki; Emmanouil K Symvoulakis; Gregory Chlouverakis; Efstathios T Detorakis
Journal:  Med Pharm Rep       Date:  2021-04-29

2.  Status of ocular trauma in hospitalized patients in Kashan, 2011: As a sample of industrial city.

Authors:  Mehdi Shaeri; Alireza Moravveji; Mohammad-Reza Fazel; Fatemeh Rangraz Jeddi
Journal:  Chin J Traumatol       Date:  2016-12-01

Review 3.  Role of Socioeconomic Status (SES) in Globe Injuries: A Review.

Authors:  Panagiotis Kousiouris; Olga Klavdianou; Konstantinos A A Douglas; Nikolaos Gouliopoulos; Klio Chatzistefanou; Maria Kantzanou; Georgios S Dimtsas; Marilita M Moschos
Journal:  Clin Ophthalmol       Date:  2022-01-05

4.  The Demographic and Social Characteristics of Patients with Ocular Foreign Bodies in a Greek Tertiary Hospital.

Authors:  Panagiotis Kousiouris; Nikolaos Gouliopoulos; Anastasia Kourtesa; Georgios S Dimtsas; Klio Chatzistefanou; Nikolaos Bouratzis; Maria Kantzanou; Marilita M Moschos
Journal:  Clin Ophthalmol       Date:  2022-07-25

5.  Epidemiology of patients hospitalized for ocular trauma in the Chaoshan region of China, 2001-2010.

Authors:  He Cao; Liping Li; Mingzhi Zhang
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

6.  Cataract Surgical Rate between 2006 and 2010 in Tehran Province.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Farhad Rezvan; Koroush Etemad; Hamidreza Gilasi; Soheila Asgari; Alireza Mahdavi; Sara Soroush; Abbasali Yekta; Akbar Fotouhi
Journal:  Iran J Public Health       Date:  2015-09       Impact factor: 1.429

7.  A reappraisal of indirect choroidal rupture using swept-source optical coherence tomography in-vivo pathology images in patients with blunt eye trauma.

Authors:  Anupriya Arthur; Nancy Magdalene Rajasekaran; Thomas Kuriakose
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.